LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: Relation to proliferation and apoptosis

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 3007-3013

  El Roz, Ali ^a   Bard, Jean Marie ^a,b   Huvelin, Jean Michel ^a   Nazih, Hassan ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b René Gauducheau Center ^*  (France)

Author keywords

ABC transporters; Cholesterol efflux; LXR; MCF 7; Proliferation; THP 1 cells

Indexed keywords

22 HYDROXYCHOLESTEROL; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL FUNCTION; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MEDIATOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CHOLESTEROL; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; HYDROXYCHOLESTEROLS; LIPOPROTEINS, HDL; ORPHAN NUCLEAR RECEPTORS; SULFONAMIDES;

EID: 84865701098     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM and Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289(5484): 1524-1529, 2000.
2. Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G and Pfahl M: A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol 14(10): 7025-7035, 1994.
3. Janowski BA, Willy PJ, Devi TR, Falck JR and Mangelsdorf DJ: An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383 (6602): 728-731, 1996.
4. Willy PJ, Umesono K, Ong ES, Evans RM, Heyman RA and Mangelsdorf DJ: LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 9(9): 1033-1045, 1995.
5. Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA and Willson TM: Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 272(6): 3137-3140, 1997.
6. Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP and Liao S: Anti-proliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 64(21): 7686-7689, 2004.
7. Chuu CP, Hiipakka RA, Kokontis JM, Fukuchi J, Chen RY and Liao S: Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 66(13): 6482-6486, 2006.
8. Pommier AJ, Alves G, Viennois E, Bernard S, Communal Y, Sion B, Marceau G, Damon C, Mouzat K, Caira F, Baron S and Lobaccaro JM: Liver X Receptor activation down-regulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 29(18): 2712-2723, 2010.
9. Scoles DR, Xu X, Wang H, Tran H, Taylor-Harding B, Li A and Karlan BY: Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low-density lipoprotein. Gynecol Oncol 116(1): 109-116, 2010.
10. Rough JJ, Monroy MA, Yerrum S and Daly JM: Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res 3: 13, 2010.
11. Vedin LL, Lewandowski SA, Parini P, Gustafsson JA and Steffensen KR: The oxysterol receptor LXR inhibits proliferation of human breast cancer cells. Carcinogenesis 30(4): 575-579, 2009.
12. Chuu CP and Lin HP: Anti-proliferative effect of LXR agonists T0901317 and 22 (R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer Res 30 (9): 3643-3648, 2010.
13. Vigushin DM, Dong Y, Inman L, Peyvandi N, Alao JP, Sun C, Ali S, Niesor EJ, Bentzen CL and Coombes RC: The nuclear oxysterol receptor LXR alpha is expressed in the normal human breast and in breast cancer. Med Oncol 21 (2): 123-131, 2004.
14. Miller RG: The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep 8(7): 519-535, 1984.
15. Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH and Samet JM: Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol 29(12): 1592-1598, 2011.
16. Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP and Frank PG: Role of cholesterol in the development and progression of breast cancer. Am J Pathol 178(1): 402-412, 2011.
17. Tiwary R, Yu W, Degraffenried LA, Sanders BG and Kline K: Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer. Breast Cancer Res 13(6): R120, 2011.
18. Zhuang L, Lin J, Lu ML, Solomon KR and Freeman MR: Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res 62(8): 2227-2231, 2002.